Jennifer Barrett

Moderna has initiated the rolling submission process for the biologics license application for its COVID-19 vaccine mRNA-1273.

Shared decision-making (SDM) and patient decision aids (PtDAs) can lower health care costs, lower utilization, and increase prevention-related care; however, these outcomes are not always guaranteed, according to the results of a recent study presented during the 2021 Pharmacy Quality Alliance Annual Meeting.

A new study, which was published in JAMA, investigated the immunogenicity in 103 pregnant and lactating individuals aged 18 to 45 years who received either the Pfizer of Moderna COVID-19 vaccines.

This indication is approved under accelerated approval based on tumor response rate and durability of response.

The CDC and FDA will further investigate the reports of blood clots following administration of the vaccine.

President Biden promised that the federal government will have enough vaccine supply to vaccinate approximately 300 million Americans by the end of May.